These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9294959)

  • 1. Participation of the Bcl-2 and Fas molecules in experimental apoptosis of spleen B lymphocytes.
    Alvarado C; Alarcón-Riquelme ME; Alcocer-Varela J; Fernández C
    Rev Invest Clin; 1997; 49(3):171-8. PubMed ID: 9294959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of Fas on cells damaged by gamma-irradiation in B6 and B6/lpr mice.
    Booker JK; Reap EA; Cohen PL
    J Immunol; 1998 Nov; 161(9):4536-41. PubMed ID: 9794379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease.
    Smith KG; Strasser A; Vaux DL
    EMBO J; 1996 Oct; 15(19):5167-76. PubMed ID: 8895561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of apoptosis and augmentation of lymphoproliferation in bcl-2 transgenic Fas/Fas ligand-defective mice.
    Tamura A; Katsumata M; Greene MI; Yui K
    Cell Immunol; 1996 Mar; 168(2):220-8. PubMed ID: 8640868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.
    Van Parijs L; Biuckians A; Abbas AK
    J Immunol; 1998 Mar; 160(5):2065-71. PubMed ID: 9498742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy.
    Reap EA; Felix NJ; Wolthusen PA; Kotzin BL; Cohen PL; Eisenberg RA
    J Immunol; 1995 Dec; 155(11):5455-62. PubMed ID: 7594564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic hypermutation of Ig genes is affected differently by failures in apoptosis caused by disruption of Fas (lpr mutation) or by overexpression of Bcl-2.
    Mastache EF; Lindroth K; Fernández C; González-Fernández A
    Scand J Immunol; 2006 Jun; 63(6):420-9. PubMed ID: 16764695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-x protects primary B cells against Fas-mediated apoptosis.
    Schneider TJ; Grillot D; Foote LC; Núñez GE; Rothstein TL
    J Immunol; 1997 Nov; 159(10):4834-9. PubMed ID: 9366408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2.
    Woodland RT; Schmidt MR; Korsmeyer SJ; Gravel KA
    J Immunol; 1996 Mar; 156(6):2143-54. PubMed ID: 8690903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice.
    Reap EA; Leslie D; Abrahams M; Eisenberg RA; Cohen PL
    J Immunol; 1995 Jan; 154(2):936-43. PubMed ID: 7529292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of c-Fos induces apoptosis of CD43+ pro-B cells.
    Hu L; Hatano M; Rüther U; Tokuhisa T
    J Immunol; 1996 Nov; 157(9):3804-11. PubMed ID: 8892609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy-induced alterations of B cell maturation and survival are differentially affected by Fas and Bcl-2, independently of BcR expression.
    Caucheteux SM; Gendron MC; Kanellopoulos-Langevin C
    Int Immunol; 2005 Jan; 17(1):55-63. PubMed ID: 15569774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent reduction of Bcl-2 expression in peripheral T cells of lpr and gld mutant mice.
    Tamura A; Yui K
    J Immunol; 1995 Jul; 155(1):499-507. PubMed ID: 7602121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
    Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of Fas cell surface expression during development of T- or B-lymphocyte lineages in normal, scid, and mutant mice lacking or overexpressing p53, bcl-2, or rag-2 genes.
    Li T; Ramirez K; Palacios R
    Cell Growth Differ; 1996 Jan; 7(1):107-14. PubMed ID: 8788039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
    Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
    J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F1-/- C57BL/6 mice overexpressing a human Bcl-2 transgene in B cells develop a mild autoimmune syndrome.
    Marín MJ; García I; Peña M; Bolívar A; Zubiaga A; Lóez-Hoyos M
    Ann N Y Acad Sci; 2005 Jun; 1051():156-65. PubMed ID: 16126955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.